Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy (Translation: The University of Toledo Journal of Medical Sciences, 2025)
Keywords: thrombospondin type 1 domain containing 7A; membranous nephropathy; melanocortin 5 receptor; melanocortin therapy